What are the consequences of the disappearing human microbiota?
Humans and our ancestors have evolved since the most ancient times with a commensal
microbiota. The conservation of indicator species in a niche-specific manner across all of the …
microbiota. The conservation of indicator species in a niche-specific manner across all of the …
Worldwide Haemophilus influenzae Type b Disease at the Beginning of the 21st Century: Global Analysis of the Disease Burden 25 Years after the Use of the …
H Peltola - Clinical microbiology reviews, 2000 - Am Soc Microbiol
Vaccination against Haemophilus influenzae type b (Hib) diseases began a quarter of a
century ago with a polysaccharide vaccine; this vaccine was followed by four different …
century ago with a polysaccharide vaccine; this vaccine was followed by four different …
Bacterial meningitis in the United States in 1995
A Schuchat, K Robinson, JD Wenger… - New England journal …, 1997 - Mass Medical Soc
Background Before the introduction of the conjugate vaccines, Haemophilus influenzae type
b was the major cause of bacterial meningitis in the United States, and meningitis was …
b was the major cause of bacterial meningitis in the United States, and meningitis was …
Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates
JP Watt, LJ Wolfson, KL O'Brien, E Henkle… - The Lancet, 2009 - thelancet.com
Background Haemophilus influenzae type b (Hib) is a leading cause of childhood bacterial
meningitis, pneumonia, and other serious infections. Hib disease can be almost completely …
meningitis, pneumonia, and other serious infections. Hib disease can be almost completely …
Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum
JB Robbins, R Schneerson… - Journal of Infectious …, 1995 - academic.oup.com
The theory proposed is that a critical level of specific serum IgG is sufficient to confer
protection against infectious diseases by inactivating the inoculum of the pathogen. This …
protection against infectious diseases by inactivating the inoculum of the pathogen. This …
Use of a Whole Genome Approach To Identify Vaccine Molecules Affording Protection against Streptococcus pneumoniae Infection
TM Wizemann, JH Heinrichs, JE Adamou… - Infection and …, 2001 - Am Soc Microbiol
Microbial targets for protective humoral immunity are typically surface-localized proteins and
contain common sequence motifs related to their secretion or surface binding. Exploiting the …
contain common sequence motifs related to their secretion or surface binding. Exploiting the …
Haemophilus influenzae type b conjugate vaccines
DF Kelly, ER Moxon, AJ Pollard - Immunology, 2004 - Wiley Online Library
Haemophilus influenzae type b (Hib) is one of the leading causes of invasive bacterial
infection in young children worldwide. During childhood, acquisition of antibody directed …
infection in young children worldwide. During childhood, acquisition of antibody directed …
Double-blind vaccine-controlled randomised efficacy trial of an investigational Shigella sonnei conjugate vaccine in young adults
D Cohen, S Ashkenazi, MS Green, M Gdalevich… - The Lancet, 1997 - thelancet.com
Background The aim of this double-blind randomised vaccine-controlled trial was to assess
the efficacy of a conjugate vaccine composed of Shigella sonnei O-specific polysaccharide …
the efficacy of a conjugate vaccine composed of Shigella sonnei O-specific polysaccharide …
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente
S Black, H Shinefield, R Baxter, R Austrian… - The Pediatric …, 2004 - journals.lww.com
Objective: To assess the direct and indirect effects of the introduction of routine use of
pneumococcal conjugate vaccine in infants and toddlers at risk for invasive disease caused …
pneumococcal conjugate vaccine in infants and toddlers at risk for invasive disease caused …
Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine
R Dagan, R Melamed, M Muallem… - Journal of Infectious …, 1996 - academic.oup.com
Children 12-18 months old were randomized to receive one dose of a conjugate heptavalent
pneumococcal vaccine, two doses of the same vaccine, or one dose of a 23-valent native …
pneumococcal vaccine, two doses of the same vaccine, or one dose of a 23-valent native …